Skip to content

Timing of Invasive Intracranial Pressure Monitoring Between Neurosurgeons and Intensive Care Physicians

Timing of Invasive Intracranial Pressure Monitoring Between Neurosurgeons and Intensive Care Physicians

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05045105
Acronym
TIMING-ICP
Enrollment
64
Registered
2021-09-16
Start date
2021-04-27
Completion date
2022-05-03
Last updated
2021-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Hypertension, Timing of Invasive Intracranial Pressure Monitoring

Brief summary

Invasive intracranial pressure monitoring takes on essential importance in patients with traumatic brain injury and in all cerebral pathologies in which intracranial hypertension is the main cause of death. Prolonged Intracranial Hypertension has been related to poor outcome and its occurrence has therefore to be assessed as soon as possible. Invasive intracranial pressure monitoring performed by placing an intracerebral catheter is currently the gold standard technique for continuous ICP invasive monitoring. This maneuver has usually been performed by neurosurgeons, but recently this procedure has more often been carried out by intensivists, at the bedside. Management of intracranial pressure handling and treatment is currently achieved by joint decisions between neurosurgeons and intensive care physicians, but differences in logistic matters and in the executive availability could impact on the dose of intracranial pressure to which patient is exposed. The aim of this study is to compare timing of invasive intracranial pressure monitoring placement performed by intensive care physicians and neurosurgeons and to detect possible differences in the incidence of complications between the two groups.

Detailed description

This perspective, multicentric and observational study will enroll patients at risk for developing intracranial hypertension, for whom it is thought invasive ICP monitoring is crucial for achieving the most appropriate treatment. Indication to invasive ICP monitoring and its modalities will be set through a joint decision between neurosurgeons and intensive care physician, which will be led by clinical and instrumental data. This study will be carried out in Intensive Care Unit and in Neurosurgery department. Sample size assessment: Sample size assessment has been performed by Monte Carlo simulation (B=500). Assuming a timing decrease (T2-T1) of 20 minutes in the procedure carried out by an intensivist compared to a neurosurgeon, with a mean time of 100 minutes, a standard deviation between center and intra-center of 10 minutes, 16 centers, each one with the same number of patients and a balance 1:1 between the two groups (intensivist:neurosurgeon), a total number of 64 patients (32 treated by intensivists and 32 by neurosurgeons), it allows us to evaluate the interest effect with a power of at least 95%, and a significance level of 5%. This elevated power has been decided according to the simplicity of the assumed design (same number of entities and conditions for center) and not evaluable in his real configuration. Statistical analysis plan: Delta time in the placement of invasive ICP monitoring is assumed as T2-T1, declared in minutes. Typology operator (neurosurgeon vs intensivist) impact on delta time will be evaluated through a multilevel model elaborated with a linear mixed model. The model will assume the center in which the maneuver is carried out as clustering factor. The place where the maneuver is carried out (intensive care unit vs operating room) and the confidence in performing the procedure (routine vs sporadic, defined as less than 5 times a year) will be assumed as covariates. The incidence of complications, valued as a binary variable, will be evaluated through logistic model GLMM (generalized linear mixed model) with the organization exposed in the dedicated data element. Timings are defined as: * T0: suspect of pathology at risk for developing intracranial hypertension * T1: neurointensive and neurosurgical indication to invasive ICP monitoring (it can be the time when brain CT is performed or, in the absence of a brain CT, the time at which indication to invasive ICP monitoring is stated) * T2: skin incision at skull for BOLT/EVD placement Place of positioning: The place (intensive care unit or operating room) where the procedure is carried out must be declared.

Interventions

OTHERTime necessary for ICP catheter placement by Intensive Care Physician vs Neurosurgeon following indication

Time necessary for ICP catheter placement by Intensive Care Physician vs Neurosurgeon following indication and complications related to the maneuver between the two cohorts will be evaluated and compared.

Sponsors

Università degli Studi di Brescia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients with acute cerebral pathology with urgent indication to invasive intracranial pressure monitoring (intraparenchymal and intraventricular) * Age greater than or equal to 18 years

Exclusion criteria

* Patients in whom indication to intraventricular catheter placement is stated for reasons other than the need of ICP monitoring (e.g. CSF drainage) * Patients in whom indication to invasive intracranial pressure monitoring is not an urgent request * Patients in whom a significative coagulation disorder is a contraindication for procedure

Design outcomes

Primary

MeasureTime frameDescription
To compare timing of invasive intracranial pressure monitoring performed by intensive care physicians and neurosurgeonsThe time frame, will be from when the suspicion of a potential increase in ICP is given to when the actual skin incision for the insertion of the invasive catheter placement is performed. From indication up to 5 hours.The time frame, which also represents the main outcome of this study, is defined as the time-difference between the moment when indication of invasive ICP monitoring is given and the moment when the skin incision is performed for ICP monitoring placement.

Secondary

MeasureTime frameDescription
Comparative evaluation of post-procedural complications between intensivists and neurosurgeonsprocedure to hospital discharge (in case of malfunction of the catheter, time is up to 12 hours after placement)Comparative evaluation of post-procedural complications (meningitis, catheter-placement related bleedings, wrong placement) between intensivists and neurosurgeons
Length of ICU stayICU admission to discharge, up to 30 daysLength of ICU stay
length of hospital stayhospital admission to discharge, up to 30 dayslength of hospital stay
duration of mechanical ventilationfrom initiation of mechanical ventilation to weaning from the ventilator, up to 30 days.duration of mechanical ventilation
Glasgow Outcome Score at 3 months3 months after the acute eventGlasgow Outcome Score

Countries

Italy

Contacts

Primary ContactFrank A Rasulo
frank.rasulo@gmail.com+39 3393366290
Backup ContactGiovanni Chiarini
giovanni.chiarini88@gmail.com+39 3473926790

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026